Automating Pharmacopeial Calculations in LIMS: USP <921> Karl Fischer, USP <711> Dissolution & Assay Worksheets

For decades, QC laboratories relied on standalone Microsoft Excel workbooks to compute assay concentrations, moisture contents, and dissolution profiles. However, unvalidated spreadsheets represent one of the most cited data integrity deficiencies during US FDA and WHO GMP inspections.

Key compliance vulnerabilities of spreadsheets include: • Hidden formulas and unprotected cells that allow intentional or accidental manipulation of dilution factors. • Lack of contemporaneous ALCOA+ audit trails capturing when raw values were altered or discarded. • Inability to link volumetric titrant normality factors or reference standard potencies automatically to primary inventory lots.

Novaqis LIMS replaces spreadsheet dependency with native, validated calculation worksheets. When configuring a test specification (STP), method developers define mathematical models using standard pharmacopeial symbols: • Dynamic Variable Binding: Bind variables directly to calibrated analytical balances, automated titrators, HPLC peak areas, and reference standard purity certificates. • Real-Time Formula Verification: System evaluates expressions across multi-replicate runs, calculating mean, standard deviation, and relative standard deviation (%RSD) automatically. • Boundary & Outlier Detection: Instant flagging of individual replicates that fail acceptance criteria or trigger Dixon's Q-test / Grubbs outlier alarms.

Karl Fischer titrations require precision standardization against sodium tartrate dihydrate. Novaqis LIMS calculates water factor (F in mg/mL) using the formula: F = (Weight of Water or Tartrate in mg) / (Titrant Volume in mL)

Upon sample titration, the system consumes the active titrant lot factor, subtracts the blank drift, and computes % Water on as-is or anhydrous basis per USP <921> Method 1, immediately evaluating against finished product limits.

Dissolution testing requires staged acceptance evaluation: • Stage 1 (S1): Each of 6 individual dosage units must not be less than Q + 5%. • Stage 2 (S2): If S1 fails, 6 additional units are tested. The average of all 12 units is >= Q, with no unit < Q - 15%. • Stage 3 (S3): If S2 fails, 12 additional units are tested (total 24). The average is >= Q, not more than 2 units are < Q - 15%, and no unit is < Q - 25%.

Novaqis LIMS dynamically enforces USP <711> staging logic, automatically prompting analysts for S2/S3 testing only when criteria are not satisfied, locking out arbitrary result acceptance.